Table 2. Treatment Characteristics and Outcomes of the 32 Patients Included.

Treatment and outcomes
Therapies proposed
Weight loss	29 (90.6%)
Pharmacological treatment	30 (93.8%)
Acetazolamide alone	16 (50.0%)
Acetazolamide and subsequent topiramate	10 (31.3%)
Acetazolamide and subsequent furosemide	1 (3.1%)
Acetazolamide and subsequent corticotherapy	2 (6.3%)
Surgical treatment	14 (43.8%)
Ventriculoperitoneal shunt	13 (40.6%)
Optic nerve fenestration	1 (3.1%)
12 months follow-up
Initial medical treatment failure	14 (43.8%)
Papilledema improvement	25 (78.1%)
≥ 50% improvement in headache frequency	20 (62.5%)